The Brighterside of News on MSN5d
Zebrafish could help scientists fully restore human vision loss
Neuronal degeneration leading to visual impairment or blindness remains a critical challenge in human health. Unlike humans, ...
f-ORG technique detects early eye disease through light-response analysis
Eye diseases often develop asymptomatically for many years. ICTER scientists have developed the f-ORG technique, which ...
BioWorld3d
CHK2 inhibition alleviates photoreceptor degeneration in preclinical Bardet-Biedl syndrome
Bardet-Biedl syndrome (BBS) is a ciliopathy that leads to progressive blindness due to degeneration of cone photoreceptors, but the mechanisms behind this are not well understood. The syndrome is ...
Medical Dialogues13d
Bayer-BlueRock Therapeutics bags USFDA Fast Track Designation for primary photoreceptor diseases treatment
Berlin: Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, ...
pharmaphorum9d
Neurotech's cell therapy gets FDA nod for eye disorder MacTel
Neurotech Pharma's cell therapy Encelto has become the first FDA-approved treatment for idiopathic macular telangiectasia ...
Ophthalmology Times13d
Cognition Therapeutics publishes research on the potential of zervimesine (CT1812) for treating dry AMD
Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...